MARKER THERAPEUTICS INC (MRKR)

US57055L2060 - Common Stock

4.22  +0.02 (+0.48%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
3.31M9.01M1.24M470.00K210.00K
Operating Expenses
17.89M38.96M40.72M29.35M22.74M
Research and Development
10.42M26.14M27.79M18.88M12.76M
Selling, General, and Administrative Expenses
7.48M12.82M12.92M10.47M9.98M
Operating Income
-14.58M-29.95M-39.47M-28.89M-22.53M
Interest Income/Expense
539.16K250.00K10.00K180.00K1.10M
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
0.00-230.00K-2.41MN/AN/A
Income Before Taxes
-14.04M-29.93M-41.88M-28.71M-21.43M
Income Tax
3.68KN/AN/AN/AN/A
Net Income
-8.24M-29.93M-41.88M-28.71M-21.43M
EBITDA
N/A-27.16M-37.32M-28.40M-22.42M
 
Per Share Data
EPS Diluted Total Ops
-0.93-3.58-5.47-6.10-4.70
Non GAAP EPS
N/A-3.58-3.86-0.62-0.47
 
Statistics
Profit Margin
-248.76%-332.19%-3377.42%-6108.51%-10204.76%
Operating Profit Margin
-440.37%-332.41%-3183.06%-6146.81%-10728.57%

All data in USD

Charts